Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients.
Chouchana L, Boujaafar S, Gana I, Preta LH, Regard L, Legendre P, Azoulay C, Canouï E, Zerbit J, Carlier N, Terrier B, Kernéis S, Batista R, Treluyer JM, Zheng Y, Benaboud S. Chouchana L, et al. Among authors: canoui e. Ther Drug Monit. 2021 Feb 1;43(1):131-135. doi: 10.1097/FTD.0000000000000838. Ther Drug Monit. 2021. PMID: 33230045 Free PMC article.
Encephalitis in travellers: a prospective multicentre study.
Picard L, Mailles A, Fillâtre P, Tattevin P, Stahl JP; ENCEIF scientific committee; investigators group. Picard L, et al. J Travel Med. 2023 Apr 5;30(2):taac145. doi: 10.1093/jtm/taac145. J Travel Med. 2023. PMID: 36461934 Free article.
Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa.
Dinh A, Wyplosz B, Kernéis S, Lebeaux D, Bouchand F, Duran C, Béraud G, Lazaro P, Davido B, Hénard S, Canouï E, Ferry T, Wolff M. Dinh A, et al. Among authors: canoui e. Int J Antimicrob Agents. 2017 Jun;49(6):782-783. doi: 10.1016/j.ijantimicag.2017.04.001. Epub 2017 Apr 12. Int J Antimicrob Agents. 2017. PMID: 28412272 No abstract available.
Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation.
Pérut V, Gauzit R, Kernéis S, Canouï E, Chedhomme FX, Batista R, Conort O, Bouam S, Raymond J, Loubinoux J, Chevallier A, Salmon-Ceron D. Pérut V, et al. Among authors: canoui e. Med Mal Infect. 2019 May;49(3):187-193. doi: 10.1016/j.medmal.2018.10.002. Epub 2018 Nov 9. Med Mal Infect. 2019. PMID: 30420165
[No title available]
[No authors listed] [No authors listed] PMID: 32663849
A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir.
Joumaa H, Regard L, Carlier N, Chassagnon G, Alabadan E, Canouï E, L'honneur A, Rozenberg F, Burgel PR, Roche N. Joumaa H, et al. Among authors: canoui e. Respir Med Res. 2020 Nov;78:100780. doi: 10.1016/j.resmer.2020.100780. Epub 2020 Jul 15. Respir Med Res. 2020. PMID: 32759053 Free PMC article. No abstract available.
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient.
Szwebel TA, Veyer D, Robillard N, Eshagh D, Canoui E, Bruneau T, Contejean A, Azoulay C, Serrano T, Hueso T, Izquierdo L, Rozenberg F, Terrier B, Vignon M, Laurent-Puig P, Taly V, Bélec L, Kernéis S, Lacombe K, Péré H. Szwebel TA, et al. Among authors: canoui e. Stem Cell Rev Rep. 2021 Feb;17(1):296-299. doi: 10.1007/s12015-020-10107-5. Epub 2021 Jan 5. Stem Cell Rev Rep. 2021. PMID: 33403488 Free PMC article.
71 results